Anja heads our Life Sciences & Healthcare group in Germany. She is a specialist lawyer for intellectual property law, admitted as representative before the Unified Patent Court (UPC) and has specialized in patent law for 20 years. Anja manages and coordinates complex, multinational patent infringement proceedings and drafts infringement and nullity opinions. Further, she negotiates license as well as research and development negotiations.

 

She advises on parallel opposition and nullity proceedings before the European Patent Office, the Federal Patent Court and the Federal Supreme Court. In particular, Anja represents clients from the fields of pharmaceuticals, biotech, personalised medicine and precision medicine as well as from the chemical and medical device industries and advises on related issues of digitisation. Having spent time in Geneva, Strasbourg, Tokyo and London, Anja has intercultural competence and language skills (including English, French and Japanese).

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

2024年3月22日
Briefing

作者 Dr. Anja Lunze, LL.M. 以及 Tobias Baus, LL.M., Dipl.-Ing.

点击此处了解更多
酒店与休闲

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

2024年2月23日
In-depth analysis

作者 Dr. Anja Lunze, LL.M. 以及 Tobias Baus, LL.M., Dipl.-Ing.

点击此处了解更多
UPC

Forum Shopping at the UPC

Different routes for infringement and revocation proceedings?

2024年2月6日
In-depth analysis

作者

点击此处了解更多
专利与创新

11. January 2024 – CJEU Case C 473/22: Mylan AB v Gilead and others

2024年1月12日
Quick read

作者 Dr. Anja Lunze, LL.M. 以及 Dr. Aurel-Damian Roscher, LL.M.

点击此处了解更多

与我会面:

7月9日

18:00

慕尼黑

Women in Patents Cocktail

更多